早期vvECMO植入可能与ARDS中较低的死亡率有关
Peter Rosenberger1, Lisa Korell2, Helene A Haeberle2
1Department of Anesthesiology and Intensive Care Medicine, University Hospital Tübingen, Hoppe-Seyler-Straße 3, 72076, Tübingen, Germany. peter.rosenberger@medizin.uni-tuebingen.de.
Respiratory research
|September 26, 2023
概括
在严重急性呼吸困扰综合征 (ARDS) 早期启动毒性体外膜氧化 (vvECMO) 可能会降低死亡率. 在入侵性机械通风 (IMV) 五天内接受vvECMO的患者的死亡率较低.
科学领域:
- 临界护理医学 临界护理医学
- 呼吸系统医学 呼吸系统医学
- 心肺支 提供心肺支
背景情况:
- 严重的急性呼吸困扰综合征 (ARDS) 通常需要先进的呼吸支持.
- 静脉外体膜氧化 (vvECMO) 是ARDS中耐火性低氧症的关键疗法.
- 启动vvECMO的最佳时间仍然是一个临床不确定性的领域.
研究的目的:
- 调查vvECMO启动前侵入性机械通风 (IMV) 持续时间与患者死亡率之间的关联.
- 为了确定早期的vvECMO支持是否会改善严重ARDS患者的结果.
主要方法:
- 用vECMO治疗的严重ARDS患者的回顾性观察性研究.
- 包括来自学术重症监护病房的158名患者.
- 多变量逻辑回归分析,以评估IMV持续时间对28天死亡率的影响.
主要成果:
- 在vvECMO之前,IMV的中位持续时间在幸存者 (1天) 与非幸存者 (4天) 相比显著更短.
- 后勤回归显示IMV持续时间和死亡率之间存在关联.
- 在IMV5天内接受vvECMO的患者的28天和住院死亡率显著降低.
结论:
- 在严重的ARDS患者中,早期启动vvECMO治疗似乎与死亡率降低有关.
- 在IMV的前5天内启动vECMO可能是改善生存的关键因素.
更多相关视频
相关概念视频
Acute Respiratory Failure-II
263
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
263
Mechanical Ventilation II: Invasive Ventilation
177
Ventilators are essential medical equipment used to aid patients with respiratory difficulties. Their primary function is to assist or replace spontaneous breathing by providing mechanical ventilation. There are two general classes of mechanical ventilators: negative-pressure and positive-pressure ventilators.
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
177
Acute Respiratory Failure-III
209
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
209
Acute Respiratory Failure-V
155
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
155
Pulmonary Embolism I: Introduction
7
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
7
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
10
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
10


